According to the research report released on February 23, the first purchase rating of Acrobiosystems Co.Ltd(301080) (301080.sz, latest price: 176.84 yuan) was given. The reasons for rating mainly include: 1) strong demand for recombinant protein reagent and continuous expansion of market scale; 2) Driven by the two round strategy of "focusing on the industrial end + global market development", the recombinant protein business showed rapid growth. Risk tips: failure risk of new product research and development, uncertainty risk of industry demand, uncertainty risk of covid-19 business, loss risk of core technicians and exchange rate fluctuation risk.
AI comments: Acrobiosystems Co.Ltd(301080) in the past month, it has received the attention of three research reports of securities companies and bought three. The average target price is 230 yuan, 53.16 yuan higher than the latest price of 176.84 yuan, and the average target price has increased by 30.06%.
